Stay updated on Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial

Sign up to get notified when there's something new on the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Removed MedlinePlus Genetics topic on multiple myeloma; reduces coverage of that genetic/medical topic on the page.
    Difference
    0.2%
    Check dated 2025-10-12T14:37:28.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Update to v3.2.0 with an added MedlinePlus Genetics topic (Multiple myeloma) and a government operating status notice; old v3.1.0 was removed.
    Difference
    3%
    Check dated 2025-10-05T10:23:38.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Core topic coverage updated from older multiple myeloma terms to a broader “Multiple myeloma” entry with a new revision v3.1.0; older terms like “Plasma cell myeloma” and prior revision v3.0.2 removed.
    Difference
    0.5%
    Check dated 2025-09-28T03:17:43.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; removed the 'Back to Top' element.
    Difference
    0.2%
    Check dated 2025-09-13T17:17:09.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated to include information on Multiple myeloma under MedlinePlus Genetics topics, and the version has been revised from v3.0.0 to v3.0.1.
    Difference
    0.4%
    Check dated 2025-09-06T14:55:38.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of new facility names and locations, as well as updates to medical terms related to plasma cell myeloma and various compounds. Notably, several previous terms and topics related to multiple myeloma and various pharmacological agents have been removed.
    Difference
    4%
    Check dated 2025-08-30T11:33:24.000Z thumbnail image

Stay in the know with updates to Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page.